T. Rowe Price Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2M | Sell |
|
|||||
|
2025
Q1 | $18.2M | Sell |
|
|||||
|
2024
Q4 | $44.6M | Sell |
|
|||||
|
2024
Q3 | $97.6M | Sell |
|
|||||
|
2024
Q2 | $190M | Buy |
|
|||||
|
2024
Q1 | $109M | Sell |
|
|||||
|
2023
Q4 | $110M | Sell |
|
|||||
|
2023
Q3 | $154M | Buy |
|
|||||
|
2023
Q2 | $146M | Sell |
|
|||||
|
2023
Q1 | $248M | Sell |
|
|||||
|
2022
Q4 | $490M | Sell |
|
|||||
|
2022
Q3 | $762M | Buy |
|
|||||
|
2022
Q2 | $485M | Buy |
|
|||||
|
2022
Q1 | $417M | Sell |
|
|||||
|
2021
Q4 | $618M | Sell |
|
|||||
|
2021
Q3 | $938M | Buy |
|
|||||
|
2021
Q2 | $522M | Sell |
|
|||||
|
2021
Q1 | $306M | Buy |
|
|||||
|
2020
Q4 | $140M | Buy |
|
|||||
|
2020
Q3 | $69.9M | Sell |
|
|||||
|
2020
Q2 | $65.3M | Buy |
|
|||||
|
2020
Q1 | $15.7M | Sell |
|
|||||
|
2019
Q4 | $22.1M | Buy |
|
|||||
|
2019
Q3 | $12.7M | Sell |
|
|||||
|
2019
Q2 | $12.2M | Buy |
|
|||||
|
2019
Q1 | $16M | Buy |
|
|||||
|
2018
Q4 | $11.9M | Buy |
|